PSGL-1 immunotherapy to activate anti-tumor inflammatory response

China |  News | 0 Comment | 18 Nov, 2019

3SBio Inc. and Verseau Therapeutics, Inc. on 18 Nov 2019 announced the selection of VTX-0811, a monoclonal antibody targeting PSGL-1, as the first licensed program under thei...Read more

BeiGene receives its first FDA approval

China |  News | 0 Comment | 18 Nov, 2019

BeiGene, Ltd., China, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of c...Read more

I-Mab to kick off clinical trials for monoclonal antibody TJM2 in China

China |  News | 0 Comment | 15 Nov, 2019

I-Mab Biopharma ("I-Mab"), a China and U.S.-based clinical-stage biopharmaceutical company exclusively focused on the discovery and development of novel or highly differentiated b...Read more

111 to establish healthcare retail channel with HEC

China |  News | 0 Comment | 15 Nov, 2019

111, Inc., a leading integrated online and offline healthcare platform, announced  that it will establish an integrated online and offline healthcare retail channel with HEC Group. The...Read more

Thermo Fisher opens customer solution center in China

China |  News | 0 Comment | 14 Nov, 2019

Thermo Fisher Scientific Inc., the world leader in serving science, has announced the official opening of a Customer Solution Center in Shanghai, China. This follows the recent announcement...Read more

Novaliq, Jiangsu Hengrui focus on treatment of dry eye disease

China |  News | 0 Comment | 14 Nov, 2019

Novaliq GmbH, a Germany based pharmaceutical company focusing on first- and best-in-class ocular therapeutics, and Jiangsu Hengrui Medicine Co, Ltd., a fully integrated biopharmaceutical co...Read more

LEO Pharma, HitGen to develop novel class of derma drugs

China |  News | 0 Comment | 13 Nov, 2019

Denmark headquartered LEO Pharma A/S and China based HitGen Inc. are pleased to announce that HitGen and LEO Pharma expands their collaboration with a license to develop a novel class of dr...Read more

GE Healthcare, Akeso Pharma to expedite novel therapy manufacturing in China

China |  News | 0 Comment | 12 Nov, 2019

Akeso Pharmaceuticals, a biotech company specializing in the development and commercialization of novel biologics, will open a new facility in Guangzhou, China, based on GE Healthcare Life ...Read more

China approves Alzheimer's drug

China |  News | 0 Comment | 11 Nov, 2019

The State Food and Drug Administration of China (CFDA) has conditionally approved the application for the listing of the Ganlut sodium capsule (trade name “Nine Phase One”)...Read more

Roxadustat Phase III study shows positive efficacy in patients with anaemia from CKD

China |  News | 0 Comment | 11 Nov, 2019

AstraZeneca and FibroGen Inc. (FibroGen) have presented pooled efficacy and cardiovascular (CV) safety analyses from the pivotal Phase III programme assessing roxadustat for the treatment o...Read more

E China's Hangzhou strengthens to establish world-class biomedical innovation city

China |  News | 0 Comment | 10 Nov, 2019

Hangzhou, capital of east China's Zhejiang Province, is endeavouring to build itself into a world-class biomedical innovation city like Boston. Such clarified goal indicates ...Read more

MMHP to build the world's largest human microbiome database

China |  News | 0 Comment | 08 Nov, 2019

The "Million Microbiome of Humans Project" (MMHP) was officially launched at the 14th International Conference on Genomics (ICG-14). Scientists from China, Sweden, Denmark,&n...Read more

Lucence, MEDx to co-develop cutting-edge cancer care tests

China |  News | 0 Comment | 11 Nov, 2019

China based MEDx (Suzhou) Translational Medicine, and Singapore-based Lucence - a leading genomic medicine company - have announced an agreement to pursue a strategic partnership in China t...Read more

AstraZeneca announces three large-scale initiatives in China

China |  News | 0 Comment | 08 Nov, 2019

AstraZeneca has announced three large-scale initiatives to build on the Company’s long-standing commitment to China and advance global research and development (R&D) for innovativ...Read more

J & J and Lazada Group enter strategic partnership

China |  News | 0 Comment | 07 Nov, 2019

Johnson & Johnson Consumer Health and Lazada Group have entered a strategic partnership to incubate more brands for success in Southeast Asian and Chinese markets. With this collaborat...Read more

Aeromics, Simcere team up for anti-edema therapy in Greater China

China |  News | 0 Comment | 06 Nov, 2019

Simcere Pharmaceutical Group and Aeromics, Inc. have announced collaboration and exclusive license agreement for AER-271, a clinical-stage anti-edema therapy, being developed for the treatm...Read more

Amgen to expand oncology presence in China

China |  News | 0 Comment | 05 Nov, 2019

Amgen has announced that it has entered into a strategic collaboration with BeiGene that will significantly accelerate Amgen's plans to expand its oncology presence in China, the world...Read more

Orsiro coronary DES receives market approval in China

China |  News | 0 Comment | 04 Nov, 2019

BIOTRONIK announced that its Orsiro® coronary drug-eluting stent (DES) has been approved for sale in China by the National Medical Products Administration. The company ex...Read more